Click here to read this study in the Lancet.
©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.
The post #VisualAbstract: Atezolizumab and Chemotherapy Improve Outcomes in Advanced or Recurrent Endometrial Cancer first appeared on Physician's Weekly.